How many institutions own NPHC stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own NPHC shares is 1, representing N/A of the company's common stock.

Who are the major shareholders selling Nutra Pharma Corp. stock?

FISHER ASSET MANAGEMENT, LLC, in the last quarter, reduced its stake in NPHC by -100% restricting it's holding to 0 shares of worth nearly -. N/A also lessened N/A of the NPHC shares from its portfolio, reducing its holding to - shares of worth -. N/A also shunned NPHC shares holding by N/A last quarter which brought its holding to - shares worth -.

Investors who are buying NPHC stock?

As per its latest 13F filing, N/A increased its stake in NPHC by N/A in the last quarter. The institutional holder raised its holding to - shares having worth more than -. N/A also added N/A more shares of NPHC to its portfolio, raising its holding to - shares of worth -. N/A also increased its NPHC shares holding by N/A which brought its holding to - shares worth -.

NPHC's major insiders: who are they?

The insider with the most stakes in NPHC is DEITSCH RIK J , President, CEO at the company. Additionally, NPHC stock is highly held by President - ReceptoPharm Rumph Harold Henry and director Lonky Stewart Alan among others.

Did an insider recently sell NPHC stock?

Company executives, directors, and other insiders own 1.02% percent of Nutra Pharma Corp.'s stock. Within the last six months, there have been 0 transaction(s) in which NPHC insiders have sold stock, totaling 0 shares. Insiders that have sold shares include SARTORI BRUNO, RUMPH HAROLD HENRY, and FLAX MICHAEL.

Which insider recently purchased NPHC stock?

There have been 0 transaction(s) during the past 6-months in which Nutra Pharma Corp. insiders have bought stock, totalling 0 shares

How much of NPHC does insiders own?

Around 0 Nutra Pharma Corp. shares are held by insiders, which represents about 1.02% of NPHC stock.

Who is the insider with the largest stake?

NPHC President, CEO, DEITSCH RIK J holds the largest portfolio of the company's shares. NPHC shares owned by DEITSCH total nearly 43.3 million.

Which institution holds the most shares in NPHC?

GOFEN & GLOSSBERG LLC /IL/ is the largest institutional owner in NPHC which holds 500 thousand shares worth - or 0.01% of the total NPHC shares outstanding followed by FISHER ASSET MANAGEMENT, LLC with ownership of 0 shares representing 0% of the NPHC ownership. GOFEN & GLOSSBERG LLC /IL/ is the third largest stakeholder with 500 thousand shares or 0.01% of the ownership worth more than $1.00K.

Is Nutra Pharma Corp. stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the NPHC is concerned, it is a stock which is optionable.

Is there a short position on NPHC's shares?

Number of NPHC shares short is N/A. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding NPHC shares are there?

As of today, N/A shares of NPHC are outstanding.

Is there many float in NPHC stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, NPHC has N/A shares in float.

NPHC short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for NPHC is N/A.

Stock Ideas

NPHC Stock Ownership Breakdown

OTC : NPHC

Nutra Pharma

$0.00

Open: 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

N/A

Short % of Float

N/A

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

1.02% Percentage of Shares held by All Insiders

N/A Percentage of Shares held by All Institutions

N/A Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About N/A of NPHC shares are held by financial institutions. GOFEN & GLOSSBERG LLC /IL/ is the top corporate investor, holding 500K shares valued at -. A 0.01% stake in Nutra Pharma Corp. is owned by the company. FISHER ASSET MANAGEMENT, LLC owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Dec 31, 2022	GOFEN & GLOSSBERG LLC /IL/	0.01%	500K	-	0	0
Dec 31, 2022	FISHER ASSET MANAGEMENT, LLC	0%	0	-	-100.06K	-100.00%
Mar 31, 2022	GOFEN & GLOSSBERG LLC /IL/	0.01%	500K	1K	0	0
Mar 31, 2022	FISHER ASSET MANAGEMENT, LLC	0%	100.06K	-	0	0
Mar 31, 2022	INVERNESS COUNSEL LLC /NY/	0%	80K	-	0	0

Insiders

Among the NPHC insiders holding of 1.02% of the stake in company, DEITSCH RIK J, President, CEO, holds the largest shares of 43.3M. RUMPH HAROLD HENRY, President - ReceptoPharm, is the second largest NPHC insider with ownership of 27.6M shares. LONKY STEWART ALAN, director, stands third with possession of 3.02M shares of that stake.

Insiders	Designation	Shares Held
DEITSCH RIK J	President, CEO	43.3M
RUMPH HAROLD HENRY	President - ReceptoPharm	27.6M
LONKY STEWART ALAN	director	3.02M
FLAX MICHAEL	Chief Financial Officer	2.61M
SARTORI BRUNO		240K
ENGELBRECHT ZIRK	Chief Financial Officer	0

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Dec 19, 2016	DEITSCH RIK J	PURCHASE	0.01	15M	75K	43.3M
Jul 05, 2016	DEITSCH RIK J	PURCHASE	0.01	15M	100.5K	28.3M
Apr 10, 2014	DEITSCH RIK J	PURCHASE	0.08	1.25M	100K	4.79M
Sep 09, 2013	RUMPH HAROLD HENRY	PURCHASE	0.00	14.8M	37K	27.6M
Sep 09, 2013	DEITSCH RIK J	PURCHASE	0.00	25M	62.5K	129.92M
Jun 27, 2013	DEITSCH RIK J	PURCHASE	0.00	25M	100K	104.92M
Dec 19, 2012	DEITSCH RIK J	PURCHASE	0.01	10M	100K	79.92M
Dec 10, 2012	DEITSCH RIK J	PURCHASE	0.01	200K	2.98K	69.92M
Aug 30, 2012	SARTORI BRUNO	SALE	0.01	303.99K	3.34K	240K
Jun 01, 2012	SARTORI BRUNO	PURCHASE	0.01	8.1K	105.3	486.1K
May 31, 2012	SARTORI BRUNO	PURCHASE	0.01	10K	130	478K
May 30, 2012	SARTORI BRUNO	PURCHASE	0.01	8K	120	468K
May 22, 2012	SARTORI BRUNO	PURCHASE	0.01	7K	77	460K
Apr 26, 2012	SARTORI BRUNO	PURCHASE	0.01	105K	1.16K	453K
Apr 25, 2012	SARTORI BRUNO	PURCHASE	0.01	68K	782	348K
Apr 24, 2012	SARTORI BRUNO	PURCHASE	0.01	10K	135	280K
Apr 23, 2012	SARTORI BRUNO	PURCHASE	0.01	5K	62.5	245K
Apr 23, 2012	DEITSCH RIK J	PURCHASE	1741.88	148K	257.8M	62.22M
Jan 20, 2011	LONKY STEWART ALAN	PURCHASE	0.13	10K	1.3K	3.02M
Dec 21, 2010	LONKY STEWART ALAN	PURCHASE	0.08	10K	800	3.01M
Apr 09, 2010	RUMPH HAROLD HENRY	SALE	0.39	400K	156K	3.8M
Feb 17, 2010	RUMPH HAROLD HENRY	PURCHASE	0.46	50K	23K	4.2M
Feb 12, 2010	RUMPH HAROLD HENRY	PURCHASE	0.40	50K	20K	4.25M
Feb 03, 2010	RUMPH HAROLD HENRY	PURCHASE	0.37	50K	18.5K	4.3M
Jan 21, 2010	RUMPH HAROLD HENRY	PURCHASE	0.33	50K	16.5K	4.35M
Mar 14, 2008	DEITSCH RIK J	PURCHASE	0.03	48M	1.2M	54.5M
Mar 13, 2008	DEITSCH RIK J	PURCHASE	0.03	5M	125K	6.5M
Nov 30, 2003	FLAX MICHAEL	SALE	200000.00	400K	80B	2.61M
Nov 30, 2003	ENGELBRECHT ZIRK	SALE	119400.00	276K	32.95B	0

Frequently Asked Questions

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.